[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100493719":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":28,"locations":37,"responsibleParty":55,"collaborators":10,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":10,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":78,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Göteborg University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational - all",null,"All included stroke patients.",[13],"Other: Observational - all",[15],{"type":6,"name":9,"description":16,"armGroupLabels":17,"otherNames":10},"All stroke patients are included.",[9],[19,23,26],{"name":20,"affiliation":21,"role":22},"Christina Jern, MD, PhD","Inst. of Biomedicine, the Sahlgrenska Academy, Univ. of Gothenburg","PRINCIPAL_INVESTIGATOR",{"name":24,"affiliation":25,"role":22},"Turgut Tatlisumak, MD, PhD","Dept. of Neurology, Sahlgrenska Univ. Hosp., Gothenburg",{"name":27,"affiliation":25,"role":22},"Katarina Jood, MD, PhD",[29,33],{"name":20,"role":30,"phone":31,"phoneExt":10,"email":32},"CONTACT","+46-31-3435720","christina.jern@neuro.gu.se",{"name":34,"role":30,"phone":35,"phoneExt":10,"email":36},"Jood Katarina, MD, PhD","+46-31-342 90 52","katarina.jood@neuro.gu.se",[38],{"facility":39,"status":40,"city":41,"state":10,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Department of Neurology, Department of Neurorehabilitation and Department of Clinical Genetics, Sahlgrenska University Hospital","RECRUITING","Gothenburg","SE-41345","Sweden","SE",{"type":46,"coordinates":47},"Point",[48,49],11.96679,57.70716,{"lat":49,"lon":48},[52],{"name":20,"role":30,"phone":53,"phoneExt":10,"email":54},"031-3435720","david.aberg@gu.se",{"type":56,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100493719","find-stroke-recovery---a-longitudinal-study-100493719",false,"NCT05708807","FIND Stroke Recovery - A Longitudinal Study","FIND Stroke Recovery: A Longitudinal Frequent Evaluation Long-term Follow-up Study","FIND","Investigators enrol patients presenting with first-ever ischemic stroke or intracerebral haemorrhage admitted to the stroke units at the Sahlgrenska University Hospital in Gothenburg, Sweden.\n\nThe inclusion criteria are:\n\n• first-ever acute ischemic stroke; or intracerebral hemorrhage.\n\nThe exclusion criteria are:\n\n* pre-stroke mRS score of ≥3;\n* severe neurodegenerative disease, cerebral neoplasm or terminal illness; and\n* patients considered unlikely to be able to participate in or to understand and\u002For comply with study procedures during follow-up visits at the hospital.","ALL","18 Years",{"count":68,"type":69},600,"ESTIMATED","OBSERVATIONAL","Stroke survivors frequently suffer disabilities including motor and cognitive problems, impairments in speech and vision, depression, and several other disabilities that worsen their quality of life. Some will recover fully after stroke and others will have permanent impairments. Few studies show trajectories of recovery in different domains after stroke, hence recovery time-lines are not fully known. Also, the whole range of mechanisms leading to recovery are not precisely known (1). To monitor those mechanisms one can utilize biomarkers.\n\nIn parallel to the studies of recovery, studies on time series of biomarkers after stroke are limited (2). Hence, a crucial first step to increase knowledge on biomarkers of stroke recovery is to gain a better understanding of the time course of both stroke recovery and biomarker patterns. Biomarkers can later be used for outcome predictions after stroke.",[73,74,75,76,77],"Stroke","Stroke Hemorrhagic","Stroke, Ischemic","Risk Factor, Cardiovascular","Cognitive Impairment",[79,80,81,82,83,84,85,86,87],"recovery","rehabilitation","stroke severity","plasticity","modified Rankin Scale","National Institutes of Health Stroke Scale","Fugl-Meyer assessment","blood sampling","stroke subtype","2025-03-27",{"date":90,"type":91},"2025-04-02","ACTUAL",{"date":93,"type":91},"2018-02-01",{"date":95,"type":69},"2030-12-31",{"name":5,"class":6},1]